Literature DB >> 15580300

Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively.

Chiara Porta1, Reda Hadj-Slimane, Mohamed Nejmeddine, Mathieu Pampin, Michael G Tovey, Lucile Espert, Sandra Alvarez, Mounira K Chelbi-Alix.   

Abstract

Type I interferon (IFN) enhances the transcription of the tumor suppressor gene p53. To elucidate the molecular mechanism mediating IFN-induced apoptosis, we analysed programmed cell death in response to type I (IFNalpha) or type II (IFNgamma) treatment in relation to p53 status. In two cell lines (MCF-7, SKNSH), IFNalpha, but not IFNgamma, enhanced apoptosis in a p53-dependent manner. Furthermore, only IFNalpha upregulated p53 as well as p53 target genes (Noxa, Mdm2 and CD95). The apoptotic response to IFNalpha decreased in the presence of ZB4, an anti-CD95 antibody, suggesting that CD95 is involved in this process. When p53 was inactivated by the E6 viral protein or the expression of a p53 mutant, IFNalpha-induced apoptosis and p53 target genes upregulation were abrogated. Altogether these results demonstrate that p53 plays a pivotal role in the IFNalpha-induced apoptotic response. IFNalpha-induced PML was unable to recruit p53 into nuclear bodies and its downregulation by siRNA did not alter CD95 expression. In contrast, IFNgamma-induced apoptosis is p53-independent. CD95 and IFN-regulatory factor 1 (IRF1) are directly upregulated by this cytokine. Apoptotic response to IFNgamma is decreased in the presence of ZB4 and strongly diminished by IRF1 siRNA, implicating both CD95 and IRF1 in IFNgamma-induced apoptotic response. Taken together, these results show that in two different cell lines, IFNalpha and IFNgamma, induce p53-dependent -independent apoptosis, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15580300     DOI: 10.1038/sj.onc.1208204

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Transcriptional profiling reveals a possible role for the timing of the inflammatory response in determining susceptibility to a viral infection.

Authors:  Thomas Ruby; Catherine Whittaker; David R Withers; Mounira K Chelbi-Alix; Veronique Morin; Anne Oudin; John R Young; Rima Zoorob
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  UBE3A regulates the transcription of IRF, an antiviral immunity.

Authors:  Ryohei Furumai; Kota Tamada; Xiaoxi Liu; Toru Takumi
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

3.  Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.

Authors:  Adrianos Nezos; Fotini Gravani; Anna Tassidou; Efstathia K Kapsogeorgou; Michael Voulgarelis; Michael Koutsilieris; Mary K Crow; Clio P Mavragani
Journal:  J Autoimmun       Date:  2015-07-14       Impact factor: 7.094

4.  PRDM16 Maintains Homeostasis of the Intestinal Epithelium by Controlling Region-Specific Metabolism.

Authors:  Rachel R Stine; Alexander P Sakers; Tara TeSlaa; Megan Kissig; Zachary E Stine; Chan Wook Kwon; Lan Cheng; Hee-Woong Lim; Klaus H Kaestner; Joshua D Rabinowitz; Patrick Seale
Journal:  Cell Stem Cell       Date:  2019-09-26       Impact factor: 24.633

5.  Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.

Authors:  Mathieu Pampin; Yannick Simonin; Bruno Blondel; Yann Percherancier; Mounira K Chelbi-Alix
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2.

Authors:  Sarah L Hockley; Volker M Arlt; Daniel Brewer; Ian Giddings; David H Phillips
Journal:  BMC Genomics       Date:  2006-10-16       Impact factor: 3.969

7.  Cell-specific but p53-independent regulation of vascular endothelial growth factor expression by interferons in human glioblastoma cells.

Authors:  Yongxue Yao; Toshihiko Kubota; Kazufumi Sato; Hiroaki Takeuchi; Yuji Handa; Shigeru Matsukawa
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

8.  Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.

Authors:  Mohamed Ali Maroui; Ghizlane Maarifi; Francis P McManus; Frédéric Lamoliatte; Pierre Thibault; Mounira K Chelbi-Alix
Journal:  Mol Cell Proteomics       Date:  2018-03-13       Impact factor: 5.911

9.  The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer.

Authors:  Masaharu Ishida; Makoto Sunamura; Toru Furukawa; Liviu P Lefter; Rina Morita; Masanori Akada; Shinichi Egawa; Michiaki Unno; Akira Horii
Journal:  Dig Dis Sci       Date:  2008-01-31       Impact factor: 3.199

Review 10.  Immunological considerations of modern animal models of malignant primary brain tumors.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Martin J Rutkowski; Shanna Fang; C David James; Andrew T Parsa
Journal:  J Transl Med       Date:  2009-10-08       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.